SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
批准号:
6343071
负责人:
Taolin Yi
金额:
$15.4万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2003-12-31
关键词:
biological signal transduction cell growth regulation cell nucleus confocal scanning microscopy enzyme mechanism immunofluorescence technique molecular cloning natural killer cells phosphorylation protein binding protein localization protein sequence protein tyrosine phosphatase tissue /cell culture transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract)
This application describes studies to investigate the mechanism
underlying the regulation of cell growth by the protein tyrosine
phosphatase SHP-1. SHP-1 is a SH2-domain containing tyrosine phosphatase
that has been shown in a number of systems to negatively regulate
receptor-mediated cell signaling pathways and therefore negatively
regulate cell growth. It has been most extensively studied in the
context of hematopoietic/cytokine receptors, FCgRIIB and MCH class I
receptors expressed on NK cells, where SHP-1 is recruited to the
tyrosine phosphorylated receptor and activated. The investigator has
identified nuclear proteins that are associated with SHP-1 and has
demonstrated that SHP-1 is found in the nucleus. Dr. Yi proposes to
investigate: 1) the role of two C-terminal tyrosine residues in the
nuclear localization of SHP-1; 2) the cell cycle dependence on the
interaction of SHP-1 with its nuclear binding partners; and 3) the role
of these binding partners in activating the phosphatase activity of
SHP-1. Through these studies the investigator proposes to identify a
nuclear function for SHP-1 that contributes to its role as a negative
regulator of cell growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Cancer Activities of PTPase Inhibitors
-
批准号:7054727
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
Anti-Cancer Activities of PTPase Inhibitors
-
批准号:6892827
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
Anti-Cancer Activities of PTPase Inhibitors
-
批准号:7226017
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
PTPases as Therapeutic Targets
-
批准号:6948210
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
Anti-Cancer Activities of PTPase Inhibitors
-
批准号:6609595
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
PTPases as Therapeutic Targets
-
批准号:6676490
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
PTPases as Therapeutic Targets
-
批准号:6806455
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
Anti-Cancer Activities of PTPase Inhibitors
-
批准号:6745187
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2003
-
负责人:Taolin Yi
-
依托单位:
SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
-
批准号:6138712
-
项目类别:
-
资助金额:$14.95万
-
财政年份:1999
-
负责人:Taolin Yi
-
依托单位:
SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
-
批准号:6627286
-
项目类别:
-
资助金额:$16.32万
-
财政年份:1999
-
负责人:Taolin Yi
-
依托单位:
SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
-
批准号:6490248
-
项目类别:
-
资助金额:$15.85万
-
财政年份:1999
-
负责人:Taolin Yi
-
依托单位:
SHP-1 REGULATION OF THE KU SIGNALING PATHWAY
-
批准号:2746793
-
项目类别:
-
资助金额:$15.3万
-
财政年份:1999
-
负责人:Taolin Yi
-
依托单位:
SHP-1/TYK2 INTERACTION AND ITS DEFECT IN FHLH DISEASE
-
批准号:2736705
-
项目类别:
-
资助金额:$13.64万
-
财政年份:1998
-
负责人:Taolin Yi
-
依托单位:
SHP-1/TYK2 INTERACTION AND ITS DEFECT IN FHLH DISEASE
-
批准号:6329061
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1998
-
负责人:Taolin Yi
-
依托单位:
SHP-1/TYK2 INTERACTION AND ITS DEFECT IN FHLH DISEASE
-
批准号:6124658
-
项目类别:
-
资助金额:$13.32万
-
财政年份:1998
-
负责人:Taolin Yi
-
依托单位:
海外基金